RSLS
Companies
NASDAQ
Reshape Lifesciences Inc.
Health Care
$2.56
-$108.94 (-97.70%)
Price Chart
Overview
About RSLS
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Market Cap
$5.3M
Volume
125.3M
Avg. Volume
42.8M
P/E Ratio
-1.0527778
Dividend Yield
0.00%
Employees
40.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.97
Moderate Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, RSLS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025